Comparing ormeloxifene (a contraceptive) and medroxyprogesterone acetate (hormone supplement) in heavy periods patients
Phase 2
- Conditions
- Health Condition 1: N924- Excessive bleeding in the premenopausal periodHealth Condition 2: N924- Excessive bleeding in the premenopausal period
- Registration Number
- CTRI/2024/01/061782
- Lead Sponsor
- Sri manakula vinayagar medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Reproductive age group women
Exclusion Criteria
No structural abnormality
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of ormeloxifene and medroxyprogesterone acetate in acute heavy menstrual bleedingTimepoint: 4 months
- Secondary Outcome Measures
Name Time Method To study the effect of ormeloxifene and medroxyprogesterone acetate on Endometrial thicknessTimepoint: 4 months